Published :
Tables : 220
Figures : 38
Category : Healthcare
No. of Pages : 200
Report Code : HC-1173
Cell Culture Market Introduction: The Cell Culture Market is estimated to value over USD 35.6 billion and register a CAGR of over 10.2% from the forecast period 2020 to 2027. Increasing awareness about the benefits of culture-based vaccines and rising adoption for single-use technologies are the major factors driving the market growth. Growing demand for monoclonal antibodies and rising investments for cell-based research is augmenting the market. Factors such as increasing attention towards personalized medicine and the development of many biopharmaceutical products such as therapeutic and vaccines are driving the market. Cell Culture Market Overview: The market is classified into by product, application, end-user, and region. Based on type, the cell structure is segmented into sera, media & reagents, vessels and bioreactor accessories. Sera, media & reagents are expected to dominate the growth of the market. Reagents such as antibiotics are effective towards contamination and possible toxicity and contamination detection kits are more efficient and faster than other direct culture methods. Serum-free media eliminates the risk of contamination posed by viruses. Owing to these factors, there has been a spike in the demand of sera, media and reagents thus propelling the market. In terms of application, biopharmaceutical production is expected to hold a vast share of the market. The increasing demand for therapeutic proteins is driving the demand for biopharmaceutical production thus positively influencing the market. Rising incidences of diseases have led to more demand for vaccine production which expands the market. The increasing demand for single-use technologies and growing government approvals towards cell culture-based vaccines are fueling the market. In terms of regions, North America is the global leader of the market. Government and private enterprises rising interest in vaccines related to cell culture and higher investments in cell-based research are driving the growth of the market in the region. Strong government support for R&D activities is boosting the presence of the market in the region. In terms of end-users, pharmaceutical and biotechnological companies are the front runners due to their large consumption of cell culture for bioproduction. Expansion of major biopharmaceutical players has also bolstered the market. Asia-Pacific region is predicted to be a lucrative region owing to increasing government support of emerging economies like India and China for biotech research. Large population size and government policies favoring biopharmaceutical manufacturing have lured the prominent players to penetrate into the region. Prominent players of the market are Lonza, Becton, Dickinson and Company, Merck KGaA, Corning Incorporated, CellGenix GmbH, Eppendorf AG, PromoCell GmbH, GE Healthcare, HiMedia Laboratories, Sartorius AG, InvivoGen and Irvine Scientific,Thermo Fisher Scientific, Fujifilm. Competitive Landscape: ● Thermo Fisher Scientific in 2019 invested USD 150 million to expand its capacity of lyophilized product development and sterile liquids. Their centers across Italy and the US will have aseptic filling lines alongside isolator technology which will help in strengthening the company's customer base worldwide ● Merck in 2018 opened its BioReliance biosafety testing lab in Singapore. Their new lab will offer critical testing services which would further augment the market ● Fujifilm in 2018, acquired IS JAPAN CO., LTD, and Irvine Scientific. The move helped Fujifilm enhance regenerative medicine and reagent business, hence bolstering the company's foothold in the market Cell Culture Market Segmentation : By Product Consumables Sera, Media and Reagents Vessels Bioreactor Accessories Equipment Supporting Equipment Bioreactors Storage Equipment By Application ● Biopharmaceutical Production ● Diagnostics ● Drug Screening and Development ● Stem Cell Research ● Tissue Engineering & Regenerative Medicine ● Other Applications By End-User ● Pharmaceutical & Biotechnology Companies ● Hospitals and Diagnostic Laboratories ● Research Institutes By Region ● North America ● Europe ● Asia Pacific ● Latin America ● Rest of the World FutureWise Key Takeaways: ● According to our industry experts, single-use bioreactors are expected to witness immense demand owing to the rising adoption of single-use technologies. Single-use technologies offer benefits such as low price and low contamination risk. In addition, the demand for mAbs is also fueling the demand of single-use bioreactors thus propelling the market ● Europe is expected to be a high growth profit region owing to the growing support of private investors and the government for R&D activity in countries like Germany and France. Expansion of the life science industry in the UK is also positively influencing the market. Objectives of the Study: • To provide with an exhaustive analysis on the global cell culture market by product, by application, by end-user, and by region • To cater to comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America and the rest of the world • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers, and expansions • Profiling of companies to evaluate their market shares, strategies, financial and core competencies Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization services offered are free of charge with purchase of any license of the report. • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
The Cell Culture Market is estimated to value over USD 35.6 billion and register a CAGR of over 10.2% from the forecast period 2020 to 2027. Increasing awareness about the benefits of culture-based vaccines and rising adoption for single-use technologies are the major factors driving the market growth. Growing demand for monoclonal antibodies and rising investments for cell-based research is augmenting the market. Factors such as increasing attention towards personalized medicine and the development of many biopharmaceutical products such as therapeutic and vaccines are driving the market.
Cell Culture Market Overview: The market is classified into by product, application, end-user, and region. Based on type, the cell structure is segmented into sera, media & reagents, vessels and bioreactor accessories. Sera, media & reagents are expected to dominate the growth of the market. Reagents such as antibiotics are effective towards contamination and possible toxicity and contamination detection kits are more efficient and faster than other direct culture methods. Serum-free media eliminates the risk of contamination posed by viruses. Owing to these factors, there has been a spike in the demand of sera, media and reagents thus propelling the market. In terms of application, biopharmaceutical production is expected to hold a vast share of the market. The increasing demand for therapeutic proteins is driving the demand for biopharmaceutical production thus positively influencing the market. Rising incidences of diseases have led to more demand for vaccine production which expands the market. The increasing demand for single-use technologies and growing government approvals towards cell culture-based vaccines are fueling the market.
In terms of regions, North America is the global leader of the market. Government and private enterprises rising interest in vaccines related to cell culture and higher investments in cell-based research are driving the growth of the market in the region. Strong government support for R&D activities is boosting the presence of the market in the region. In terms of end-users, pharmaceutical and biotechnological companies are the front runners due to their large consumption of cell culture for bioproduction. Expansion of major biopharmaceutical players has also bolstered the market. Asia-Pacific region is predicted to be a lucrative region owing to increasing government support of emerging economies like India and China for biotech research. Large population size and government policies favoring biopharmaceutical manufacturing have lured the prominent players to penetrate into the region.
Prominent players of the market are Lonza, Becton, Dickinson and Company, Merck KGaA, Corning Incorporated, CellGenix GmbH, Eppendorf AG, PromoCell GmbH, GE Healthcare, HiMedia Laboratories, Sartorius AG, InvivoGen and Irvine Scientific,Thermo Fisher Scientific, Fujifilm.
Competitive Landscape: ● Thermo Fisher Scientific in 2019 invested USD 150 million to expand its capacity of lyophilized product development and sterile liquids. Their centers across Italy and the US will have aseptic filling lines alongside isolator technology which will help in strengthening the company's customer base worldwide ● Merck in 2018 opened its BioReliance biosafety testing lab in Singapore. Their new lab will offer critical testing services which would further augment the market ● Fujifilm in 2018, acquired IS JAPAN CO., LTD, and Irvine Scientific. The move helped Fujifilm enhance regenerative medicine and reagent business, hence bolstering the company's foothold in the market Cell Culture Market Segmentation : By Product
By Application ● Biopharmaceutical Production ● Diagnostics ● Drug Screening and Development ● Stem Cell Research ● Tissue Engineering & Regenerative Medicine ● Other Applications By End-User ● Pharmaceutical & Biotechnology Companies ● Hospitals and Diagnostic Laboratories ● Research Institutes By Region ● North America ● Europe ● Asia Pacific ● Latin America ● Rest of the World
FutureWise Key Takeaways: ● According to our industry experts, single-use bioreactors are expected to witness immense demand owing to the rising adoption of single-use technologies. Single-use technologies offer benefits such as low price and low contamination risk. In addition, the demand for mAbs is also fueling the demand of single-use bioreactors thus propelling the market ● Europe is expected to be a high growth profit region owing to the growing support of private investors and the government for R&D activity in countries like Germany and France. Expansion of the life science industry in the UK is also positively influencing the market.
Objectives of the Study: • To provide with an exhaustive analysis on the global cell culture market by product, by application, by end-user, and by region • To cater to comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America and the rest of the world • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers, and expansions • Profiling of companies to evaluate their market shares, strategies, financial and core competencies
Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization services offered are free of charge with purchase of any license of the report. • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Global Cell Culture Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Global Cell Culture Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Cell Culture Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Cell Culture Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Cell Culture Market, By Product Historical Analysis and Forecast 2020-2027 (USD Million) 7.1. Consumables 7.1.1. Sera, Media and Reagents 7.1.1.1 Media 7.1.1.1.1 Serum-Free Media 7.1.1.1.2 Classical Media & Salts 7.1.1.1.3 Stem Cell Culture Media 7.1.1.1.4 Specialty Media 7.1.1.2 Reagents 7.1.1.2.1 Supplements & Growth Factors 7.1.1.2.2 Buffers & Chemicals 7.1.1.2.3 Cell Dissociation Reagents 7.1.1.2.4 Balanced Salt Solutions 7.1.1.2.5 Attachment & Matrix Factors 7.1.1.2.6 Antibiotics/Antimycotics 7.1.1.2.7 Contamination Detection Kits 7.1.1.2.8 Cryoprotective Reagents 7.1.1.2.9 Other Cell Culture Reagents 7.1.1.3 Sera 7.1.1.3.1 Fetal Bovine Sera 7.1.1.3.2 Adult Bovine Sera 7.1.1.3.3 Other Animal Sera 7.1.2. Vessels 7.1.2.1. Roller/Roux Bottles 7.1.2.2. Cell Factory Systems/Cell Stacks 7.1.2.3. Multiwell Plates 7.1.2.4. Flasks 7.1.2.5. Petri Dishes 7.1.3. Bioreactor Accessories 7.2. Equipment 7.2.1. Supporting Equipment 7.2.1.1. Filtration Systems 7.2.1.2. Cell Counters 7.2.1.3. Carbon Dioxide Incubators 7.2.1.4. Centrifuges 7.2.1.5. Autoclaves 7.2.1.6. Microscopes 7.2.1.7. Biosafety Cabinets 7.2.1.8. Other Supporting Equipment 7.2.2. Bioreactors 7.2.2.1. Conventional Bioreactors 7.2.2.2. Single-Use Bioreactors 7.2.3. Storage Equipment 7.2.3.1. Refrigerators & Freezers 7.2.3.2. Cryostorage Systems 8. Global Cell Culture Market, By Application Historical Analysis and Forecast 2020-2027 (USD Million) 8.1. Biopharmaceutical Production 8.1.1. Therapeutic Proteins 8.1.2. Vaccine Production 8.2. Diagnostics 8.3. Drug Screening and Development 8.4. Stem Cell Research 8.5. Tissue Engineering & Regenerative Medicine 8.6. Other Applications 9. Global Cell Culture Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million) 9.1. Pharmaceutical & Biotechnology Companies 9.2. Hospitals and Diagnostic Laboratories 9.3. Research Institutes 9.4. Cell Banks 10. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 10.2.1. U.S.A 10.2.2. Canada 10.2.3. Mexico 10.3. Market Size (USD Million) Forecast for North America 2020-2027 11. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 11.1. Introduction 11.2. Regional Market Trends 11.3. Historical Market Size (USD Million) Analysis By Country, 2015-2019 11.3.1. Brazil 11.3.2. Venezuela 11.3.3. Argentina 11.3.4. Rest of Latin America 11.4. Market Size (USD Million) Forecast for Latin America 2020-2027 12. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5. Spain 12.2.6. Russia 12.2.7. Poland 12.2.8. Switzerland 12.2.9. Rest of Western Europe 12.3. Market Size (USD Million) Forecast for Europe 2020-2027 13. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 13.2.1. Japan 13.2.2. China 13.2.3. Singapore 13.2.4. India 13.2.5. Australia and New Zealand 13.2.6. ASEAN 13.2.7. South Korea 13.2.8. Taiwan 13.2.9. Rest of Asia Pacific 13.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027 14. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 14.2.1. Saudi Arabia 14.2.2. UAE 14.2.3. South Africa 14.2.4. Egypt 14.3. Market Size (USD Million) Forecast for MEA 2020-2027 15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts) 15.1. Lonza 15.1.1. Company Overview 15.1.2. Product Portfolio 15.1.3. SWOT Analysis 15.1.4. Financial Overview 15.1.5. Strategic Overview 15.2. Becton, Dickinson and Company 15.2.1. Company Overview 15.2.2. Product Portfolio 15.2.3. SWOT Analysis 15.2.4. Financial Overview 15.2.5. Strategic Overview 15.3. Merck KGaA 15.3.1. Company Overview 15.3.2. Product Portfolio 15.3.3. SWOT Analysis 15.3.4. Financial Overview 15.3.5. Strategic Overview 15.4. Corning Incorporated 15.4.1. Company Overview 15.4.2. Product Portfolio 15.4.3. SWOT Analysis 15.4.4. Financial Overview 15.4.5. Strategic Overview 15.5 CellGenix GmbH 15.5.1. Company Overview 15.5.2. Product Portfolio 15.5.3. SWOT Analysis 15.5.4. Financial Overview 15.5.5. Strategic Overview 15.6 Eppendorf AG 15.6.1. Company Overview 15.6.2. Product Portfolio 15.6.3. SWOT Analysis 15.6.4. Financial Overview 15.6.5. Strategic Overview 15.7. PromoCell GmbH 15.7.1. Company Overview 15.7.2. Product Portfolio 15.7.3. SWOT Analysis 15.7.4. Financial Overview 15.7.5. Strategic Overview 15.8. GE Healthcare 15.8.1. Company Overview 15.8.2. Product Portfolio 15.8.3. SWOT Analysis 15.8.4. Financial Overview 15.8.5. Strategic Overview 15.9. HiMedia Laboratories 15.9.1. Company Overview 15.9.2. Product Portfolio 15.9.3. SWOT Analysis 15.9.4. Financial Overview 15.9.5. Strategic Overview 15.10. Sartorius AG 15.10.1. Company Overview 15.10.2. Product Portfolio 15.10.3. SWOT Analysis 15.10.4. Financial Overview 15.10.5. Strategic Overview 15.11. Thermo Fisher Scientific 15.11.1. Company Overview 15.11.2. Product Portfolio 15.11.3. SWOT Analysis 15.11.4. Financial Overview 15.11.5. Strategic Overview 15.12. Fujifilm 15.12.1. Company Overview 15.12.2. Product Portfolio 15.12.3. SWOT Analysis 15.12.4. Financial Overview 15.12.5. Strategic Overview 15.13. InvivoGen 15.13.1. Company Overview 15.13.2. Product Portfolio 15.13.3. SWOT Analysis 15.13.4. Financial Overview 15.13.5. Strategic Overview 15.14. Irvine Scientific 15.14.1. Company Overview 15.14.2. Product Portfolio 15.14.3. SWOT Analysis 15.14.4. Financial Overview 15.14.5. Strategic Overview 16. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics